MedTrace Logo

Statin-Intolerance Registry

NCT04975594 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-02-17

No results posted yet for this study

Summary

The Statin-Intolerance Registry will characterize the patient population suffering from statin-intolerance which is a frequent but incompletely understood patient condition with important clinical implications for atherosclerotic cardiovascular disease (ASCVD) prevention.

Patients will be systematically and prospectively included and followed by the registry.

Conditions

  • Dyslipidemias

Sponsors & Collaborators

  • University of Jena

    collaborator OTHER

  • University Hospital Dresden

    collaborator OTHER

  • Charite University, Berlin, Germany

    collaborator OTHER

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Ulrich Laufs · University of Leipzig

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04975594 on ClinicalTrials.gov